Pfizer
ABPI appoints manager from Pfizer
May 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pfizer, christine rowland
The ABPI has appointed Christine Rowland to the newly-created position of value and access manager for its commercial department. Rowland …
Pfizer will ‘suck AZ’s lifeblood’
May 7, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, bbd, cable, merger
A former boss of AstraZeneca has warned that he fears Pfizer “will act like a praying mantis and suck the …
Pfizer appeals to UK prime minister
May 6, 2014Manufacturing and Production, Sales and Marketing AstraZeneca, Cameron, Pfizer, merger, research
Pfizer has attempted to enlist the help of UK prime minister David Cameron in its campaign to buy AstraZeneca, offering …
AZ video: ‘Why we rejected Pfizer offer’
May 2, 2014Medical Communications, Sales and Marketing AstraZeneca, Pfizer, UK, buyout, merger, research
AstraZeneca has confirmed that it is not for turning when it comes to buyout offers from Pfizer and is happy …
Pfizer/AZ deal would put UK research in jeopardy
May 1, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, deal, merger, research
The UK’s medical research collective has come together to warn the government that any deal between US giant Pfizer and …
Merck’s Q1 sales drop
April 30, 2014Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales
Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …
Pfizer ‘significantly undervalued’ AstraZeneca
April 29, 2014Sales and Marketing AstraZeneca, Pfizer, acquisition, buyout, merger
AstraZeneca has broken its silence to insist that Pfizer’s financial offer in January for the company “very significantly undervalued AstraZeneca …
Pfizer makes second bid for AstraZeneca
April 28, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, acquisition, deal, merger
Pfizer has made a second attempt to buy AstraZeneca after an initial request was rejected in January. The biggest pharma …
Valeant makes $45.7 billion Allergan offer
April 23, 2014Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing
In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …
AstraZeneca ‘rejects Pfizer bid’
April 22, 2014Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger
AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …
Pfizer’s Jonathan Emms becomes new ABPI president
April 11, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, Pfizer, jonathan emms
Jonathan Emms, UK managing director of Pfizer, has taken up his appointment as president of the ABPI, after his election …
Pfizer breast cancer drug combo aces trial
April 7, 2014Femera, Pfizer, breast cancer, oncology, palbociclib
Alzheimer’s disease: pharma’s greatest challenge
April 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, Alzheimer's, Alzheimer’s, Eisai, Lunt, Pfizer, galantamine, karran, priddy
Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …
Lundbeck teams up with Lieber Institute
April 3, 2014Research and Development, Sales and Marketing Astellas, AstraZeneca, Lundbeck, Pfizer, Roche, ability, brain, lieber, lilly
Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …
Research pact joins Pfizer and Merck Serono with academics
April 3, 2014Research and Development, Sales and Marketing Lupus, Merck Serono, Pfizer, broad institute, emd, kidney
Merck’s US affiliate EMD Serono and Pfizer have entered into a research agreement with the Broad Institute to investigate autoimmune …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
